| No Longer Available | N/A | | US | Lovaza (Fish Oils), Lovaza NDA021654, Omacor NDA021853 | St. Luke's-Roosevelt Hospital Center, GlaxoSmithKline | Atrial Fibrillation | | | | |
TAVI/LAAO, NCT03088098: Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI |
|
|
| Active, not recruiting | N/A | 80 | Europe | LAAO | University of Zurich, Abbott Medical Devices | Atrial Fibrillation, Aortic Stenosis | 09/24 | 09/24 | | |
| Recruiting | N/A | 413 | RoW | left atrial appendage closure device implantation | Fu Wai Hospital, Beijing, China, Boston Scientific Corporation | Atrial Fibrillation, Left Atrial Appendage Closure | 12/23 | 12/23 | | |